Stroke

Showing NaN - NaN of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Muscle Spasticity, Hypertonia, Muscle, Cerebral Palsy Trial in San Antonio (MTR-601)

Recruiting
  • Muscle Spasticity
  • +7 more
  • San Antonio, Texas
    Worldwide Clinical Trials
Oct 31, 2023

Stroke Trial in Worldwide (Sentinel® Cerebral Protection System)

Completed
  • Stroke
  • Sentinel® Cerebral Protection System
  • Tucson, Arizona
  • +56 more
Jan 17, 2023

REpeated ASSEssment of SurvivorS in Intracerebral Hemorrhage

Enrolling by invitation
  • Intra Cerebral Hemorrhage
  • +11 more
    • Birmingham, Alabama
    • +25 more
    Jan 19, 2023

    Stroke Trial in United States (Time-To-Treatment Randomization)

    Recruiting
    • Stroke
    • Time-To-Treatment Randomization
    • Austin, Texas
    • +14 more
    Nov 2, 2022

    Diabetes, Myocardial Infarction, Stroke Trial in United States (Lifestyle Intervention, Diabetes Support and Education)

    Completed
    • Diabetes
    • +5 more
    • Lifestyle Intervention
    • Diabetes Support and Education
    • Birmingham, Alabama
    • +17 more
    Sep 27, 2022

    Stroke Trial in Worldwide (Amulet Left Atrial Appendage Occluder, WATCHMAN Left Atrial Appendage Closure)

    Active, not recruiting
    • Stroke
    • Amulet Left Atrial Appendage Occluder
    • WATCHMAN Left Atrial Appendage Closure
    • Huntsville, Alabama
    • +114 more
    Jul 8, 2022

    Stroke, PFO - Patent Foramen Ovale Trial in United States (PFO closure with GORE® CARDIOFORM Septal Occluder)

    Recruiting
    • Stroke
    • PFO - Patent Foramen Ovale
    • PFO closure with GORE® CARDIOFORM Septal Occluder
    • La Jolla, California
    • +38 more
    Jun 6, 2022

    Stroke Trial in Canada, United States (Apixaban, Aspirin)

    Recruiting
    • Stroke
    • Birmingham, Alabama
    • +181 more
    Mar 26, 2022

    Aspirin in Reducing Events in the Elderly

    Active, not recruiting
    • Functional Disability
    • +6 more
    • 100 mg enteric-coated aspirin
    • Placebo
    • Birmingham, Alabama
    • +46 more
    Apr 2, 2021

    GLORIA-AF Registry Program - Second and Third Phases

    Completed
    • Stroke
    • Atrial Fibrillation
      • Mobile, Alabama
      • +665 more
      Mar 3, 2021

      Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

      Completed
      • Stroke
      • +2 more
      • Birmingham, Alabama
      • +182 more
      Apr 14, 2020

      Stroke Trial in Baltimore, San Antonio (Treadmill Exercise, Stretching (control))

      Completed
      • Stroke
      • Treadmill Exercise
      • Stretching (control)
      • Baltimore, Maryland
      • +1 more
      Jan 21, 2020

      Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (Botulinum Toxin Type A)

      Completed
      • Pediatrics
      • +3 more
      • Botulinum Toxin Type A
      • Pasadena, California
      • +47 more
      Jul 29, 2019

      Atrial Fibrillation, Stroke Trial in Worldwide (warfarin, Dabigatran dose 1, Dabigatran dose 2)

      Completed
      • Atrial Fibrillation
      • Stroke
      • Birmingham, Alabama
      • +983 more
      Apr 8, 2019

      Stroke, Atrial Fibrillation, Embolism Trial in Worldwide (warfarin tablets, Edoxaban tablets (high dose regimen-60mg), Edoxaban

      Completed
      • Stroke
      • +2 more
      • warfarin tablets
      • +4 more
      • Birmingham, Alabama
      • +1015 more
      Feb 8, 2019

      Stroke Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Acetylsalicylic acid (Aspirin, BAY1019036), Rivaroxaban-Placebo)

      Terminated
      • Stroke
      • Rivaroxaban (Xarelto, BAY59-7939)
      • +3 more
      • Tucson, Arizona
      • +453 more
      Dec 20, 2018

      Pediatrics, Muscle Spasticity, Cerebral Palsy Trial in Worldwide (botulinum toxin Type A, Normal Saline (Placebo))

      Completed
      • Pediatrics
      • +3 more
      • botulinum toxin Type A
      • Normal Saline (Placebo)
      • Pasadena, California
      • +44 more
      Jul 16, 2018

      Stroke Trial in United States (Alteplase, Alteplase Placebo, Aspirin)

      Terminated
      • Stroke
      • Birmingham, Alabama
      • +87 more
      Jun 4, 2018

      Treatment of Stroke-An SPS3 Ancillary Study

      Completed
      • Hypertension
      • Stroke
        • Mobile, Alabama
        • +44 more
        Jul 20, 2017

        Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor

        Completed
        • Myocardial Infarction
        • +3 more
        • Ticagrelor 90 mg
        • +2 more
        • Alexander City, Alabama
        • +846 more
        Dec 18, 2015

        Carotid Artery Diseases, Stroke, Cerebral Arteriosclerosis Trial in United States (WALLSTENT® Endoprosthesis™)

        Completed
        • Carotid Artery Diseases
        • +2 more
        • WALLSTENT® Endoprosthesis™
        • Birmingham, Alabama
        • +49 more
        Aug 26, 2014

        Stroke Trial in Worldwide (Aggrenox, Clopidogrel , Micardis)

        Completed
        • Stroke
        • Birmingham, Alabama
        • +666 more
        Apr 22, 2014

        Stroke, Cerebral Ischemia, Brain Infarction Trial in Worldwide (Ancrod (Viprinex), Placebo)

        Terminated
        • Stroke
        • +2 more
        • Ancrod (Viprinex)
        • Placebo
        • Phoenix, Arizona
        • +99 more
        Dec 21, 2009